These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10917479)

  • 21. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy.
    Kinoshita T; Takasugi M; Iwamoto E; Akashi-Tanaka S; Fukutomi T; Terui S
    Am J Surg; 2006 Feb; 191(2):225-9. PubMed ID: 16442950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
    Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Controversial issues surrounding sentinel lymph node biopsy in breast cancer].
    Noguchi M
    Gan To Kagaku Ryoho; 2004 Feb; 31(2):163-7. PubMed ID: 14997745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sentinel lymph node mapping in breast cancer: a critical reappraisal of the internal mammary chain issue.
    Manca G; Volterrani D; Mazzarri S; Duce V; Svirydenka A; Giuliano A; Mariani G
    Q J Nucl Med Mol Imaging; 2014 Jun; 58(2):114-26. PubMed ID: 24835288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer.
    Albertini JJ; Lyman GH; Cox C; Yeatman T; Balducci L; Ku N; Shivers S; Berman C; Wells K; Rapaport D; Shons A; Horton J; Greenberg H; Nicosia S; Clark R; Cantor A; Reintgen DS
    JAMA; 1996 Dec; 276(22):1818-22. PubMed ID: 8946902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
    Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
    Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping sentinel lymph node in breast cancer by combined lymphoscintigraphy, blue-dye, and intraoperative gamma-probe.
    Mariani G; Villa G; Gipponi M; Bianchi P; Buffoni F; Agnese G; Vecchio C; Tomei D; Carli F; Nicolò G; Canavese G
    Cancer Biother Radiopharm; 2000 Jun; 15(3):245-52. PubMed ID: 10941531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sentinel lymph node mapping for staging breast cancer: preliminary results of a prospective study.
    Rehman S; Sardi A; Spiegler E; Colandrea J; Frishberg D
    Md Med J; 1999; 48(3):105-10. PubMed ID: 10394225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphatic tumor burden negatively impacts the ability to detect the sentinel lymph node in breast cancer.
    Vargas HI; Vargas MP; Venegas R; Gonzalez KD; Burla M; Mishkin F; Khalkhali I
    Am Surg; 2003 Oct; 69(10):886-90. PubMed ID: 14570368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?
    Specht MC; Fey JV; Borgen PI; Cody HS
    J Am Coll Surg; 2005 Jan; 200(1):10-4. PubMed ID: 15631914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sentinel node biopsy in breast cancer--a minimally invasive procedure for staging of the axilla].
    Haid A; Fritzsche H; Peschina W; Gruber-Mösenbacher U; Jasarevic S; Hillbrand E; Müller G; Köberle-Wührer R; Schmidle T; Breitfellner G
    Wien Klin Wochenschr; 1999 Mar; 111(6):219-25. PubMed ID: 10234775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Axillary nodal yields: a comparison between primary clearance and completion clearance after sentinel lymph node biopsy in the management of breast cancer.
    Chakravorty A; Sanmugalingam N; Shrestha A; Thomee E; Rusby J; Roche N; MacNeill F
    Eur J Surg Oncol; 2011 Feb; 37(2):122-6. PubMed ID: 21095094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sentinel lymph node (SLN) in breast cancer: prediction of axillary metastasis confined to the SLN spares patients further axillary dissection].
    Sato K; Hiraide H; Mochizuki H
    Nihon Geka Gakkai Zasshi; 2001 Jun; 102(6):445-8. PubMed ID: 11436505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer.
    Cox CE; Cox JM; White LB; Stowell NG; Clark JD; Allred N; Meyers M; Dupont E; Furman B; Minton S
    Ann Surg Oncol; 2006 Apr; 13(4):483-90. PubMed ID: 16523361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sentinel lymph node biopsy in breast cancer: the Lausanne experience].
    Delaloye JF; Antonescu C; Besseghir N; Genton CY; Bischof-Delaloye A; De Grandi P
    Rev Med Suisse Romande; 2000 Jun; 120(6):491-4. PubMed ID: 11014092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
    Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subsequent axillary surgery after sentinel lymph node biopsy: results from the BreastSurgANZ Quality Audit 2006-2010.
    Chong C; Walters D; de Silva P; Taylor C; Spillane A; Kollias J; Pyke C; Campbell I; Maddern G
    Breast; 2013 Dec; 22(6):1215-9. PubMed ID: 24157405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The feasibility and accuracy of the sentinel lymph node biopsy for breast carcinoma.
    Jaderborg JM; Harrison PB; Kiser JL; Maynard SL
    Am Surg; 1999 Aug; 65(8):699-703; discussion 704-5. PubMed ID: 10432076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved staging of breast cancer through lymphatic mapping and sentinel node biopsy.
    Jansen L; Nieweg OE; Valdés Olmos RA; Rutgers EJ; Peterse JL; de Vries J; Doting MH; Kroon BB
    Eur J Surg Oncol; 1998 Oct; 24(5):445-6. PubMed ID: 9800978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Internal mammary chain sentinel lymph node identification in breast cancer.
    Noguchi M; Tsugawa K; Miwa K
    J Surg Oncol; 2000 Feb; 73(2):75-80. PubMed ID: 10694642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.